Bibliotecas PUC-SP - Busca Integrada

Visceral Leishmaniasis in Mice Devoid of Tumor Necrosis Factor and Response to Treatment

por Murray, Henry W., Jungbluth, Achim, Ritter, Erika, Montelibano, Christina, Marino, Michael W.
Publicado 2000

Molecular Diagnosis of Clear Cell Sarcoma: Detection of EWS-ATF1 and MITF-M Transcripts and Histopathological and Ultrastructural Analysis of 12 Cases

por Antonescu, Cristina R., Tschernyavsky, Sylvia J., Woodruff, James M., Jungbluth, Achim A., Brennan, Murray F., Ladanyi, Marc
Publicado 2002

Immunomic analysis of human sarcoma

por Lee, Sang-Yull, Obata, Yuichi, Yoshida, Masahiro, Stockert, Elisabeth, Williamson, Barbara, Jungbluth, Achim A., Chen, Yao-Tseng, Old, Lloyd J., Scanlan, Matthew J.
Publicado 2003

Inhibition of interferon γ induced interleukin 12 production: A potential mechanism for the anti-inflammatory activities of tumor necrosis factor

por Hodge-Dufour, Jennifer, Marino, Michael W., Horton, Maureen R., Jungbluth, Achim, Burdick, Marie D., Strieter, Robert M., Noble, Paul W., Hunter, Christopher A., Puré, Ellen
Publicado 1998

CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

por Sharma, Padmanee, Shen, Yu, Wen, Sijin, Yamada, Sachiko, Jungbluth, Achim A., Gnjatic, Sacha, Bajorin, Dean F., Reuter, Victor E., Herr, Harry, Old, Lloyd J., Sato, Eiichi
Publicado 2007

Characterization of tumor necrosis factor-deficient mice

por Marino, Michael W., Dunn, Ashley, Grail, Dianne, Inglese, Melissa, Noguchi, Yuji, Richards, Elizabeth, Jungbluth, Achim, Wada, Hisashi, Moore, Malcolm, Williamson, Barbara, Basu, Sunanda, Old, Lloyd J.
Publicado 1997

Anti-CTLA-4 therapy results in higher CD4(+)ICOS(hi) T cell frequency and IFN-γ levels in both nonmalignant and malignant prostate tissues

por Chen, Hong, Liakou, Chrysoula I., Kamat, Ashish, Pettaway, Curtis, Ward, John F., Tang, Derek Ng, Sun, Jingjing, Jungbluth, Achim A., Troncoso, Patricia, Logothetis, Christopher, Sharma, Padmanee
Publicado 2009

An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Br...

por Bortoluzzo Adriana B, Tassello Jodie, Frosina Denise, Hanson Nicole C, Assis Mariane CG, Baiocchi Otávio CG, Jungbluth Achim A, Inaoka Riguel J, Alves Antonio C, Colleoni Gisele WB
Publicado en BMC Cancer (2011-09-01)

Evaluation of the Clonal Origin of Multiple Primary Melanomas Using Molecular Profiling

por Orlow, Irene, Tommasi, Diana, Bloom, Bradley, Ostrovnaya, Irina, Cotignola, Javier, Mujumdar, Urvi, Busam, Klaus J., Jungbluth, Achim A., Scolyer, Richard A., Thompson, John F., Armstrong, Bruce K., Berwick, Marianne, Thomas, Nancy E., Begg, Colin B.
Publicado 2009

Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478

por Johns, Terrance G., Luwor, Rodney B., Murone, Carmel, Walker, Francesca, Weinstock, Janet, Vitali, Angela A., Perera, Rushika M., Jungbluth, Achim A., Stockert, Elisabeth, Old, Lloyd J., Nice, Edouard C., Burgess, Antony W., Scott, Andrew M.
Publicado 2003

A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor

por Jungbluth, Achim A., Stockert, Elisabeth, Huang, H. J. Su, Collins, Vincent P., Coplan, Keren, Iversen, Kristin, Kolb, Denise, Johns, Terrance J., Scott, Andrew M., Gullick, William J., Ritter, Gerd, Cohen, Leonard, Scanlan, Matthew J., Cavanee, Webster K., Old, Lloyd J.
Publicado 2003

Intraepithelial CD8(+) tumor-infiltrating lymphocytes and a high CD8(+)/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

por Sato, Eiichi, Olson, Sara H., Ahn, Jiyoung, Bundy, Brian, Nishikawa, Hiroyoshi, Qian, Feng, Jungbluth, Achim A., Frosina, Denise, Gnjatic, Sacha, Ambrosone, Christine, Kepner, James, Odunsi, Tosin, Ritter, Gerd, Lele, Shashikant, Chen, Yao-Tseng, Ohtani, Haruo, Old, Lloyd J., Odunsi, Kunle
Publicado 2005

CT-X antigen expression in human breast cancer

por Grigoriadis, Anita, Caballero, Otavia L., Hoek, Keith S., da Silva, Leonard, Chen, Yao-Tseng, Shin, Sandra J., Jungbluth, Achim A., Miller, Lance D., Clouston, David, Cebon, Jonathan, Old, Lloyd J., Lakhani, Sunil R., Simpson, Andrew J. G., Neville, A. Munro
Publicado 2009

Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant–dependent lung carcinomas

por Li, Danan, Ji, Hongbin, Zaghlul, Sara, McNamara, Kate, Liang, Mei-Chih, Shimamura, Takeshi, Kubo, Shigeto, Takahashi, Masaya, Chirieac, Lucian R., Padera, Robert F., Scott, Andrew M., Jungbluth, Achim A., Cavenee, Webster K., Old, Lloyd J., Demetri, George D., Wong, Kwok-Kin
Publicado 2007

Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming

por Valmori, Danila, Souleimanian, Naira E., Tosello, Valeria, Bhardwaj, Nina, Adams, Sylvia, O'Neill, David, Pavlick, Anna, Escalon, Juliet B., Cruz, Crystal M., Angiulli, Angelica, Angiulli, Francesca, Mears, Gregory, Vogel, Susan M., Pan, Linda, Jungbluth, Achim A., Hoffmann, Eric W., Venhaus, Ralph, Ritter, Gerd, Old, Lloyd J., Ayyoub, Maha
Publicado 2007

CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit

por Yuan, Jianda, Gnjatic, Sacha, Li, Hao, Powel, Sarah, Gallardo, Humilidad F., Ritter, Erika, Ku, Geoffrey Y., Jungbluth, Achim A., Segal, Neil H., Rasalan, Teresa S., Manukian, Gregor, Xu, Yinyan, Roman, Ruth-Ann, Terzulli, Stephanie L., Heywood, Melanie, Pogoriler, Evelina, Ritter, Gerd, Old, Lloyd J., Allison, James P., Wolchok, Jedd D.
Publicado 2008

CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens

por Almeida, Luiz Gonzaga, Sakabe, Noboru J., deOliveira, Alice R., Silva, Maria Cristina C., Mundstein, Alex S., Cohen, Tzeela, Chen, Yao-Tseng, Chua, Ramon, Gurung, Sita, Gnjatic, Sacha, Jungbluth, Achim A., Caballero, Otávia L., Bairoch, Amos, Kiesler, Eva, White, Sarah L., Simpson, Andrew J. G., Old, Lloyd J., Camargo, Anamaria A., Vasconcelos, Ana Tereza R.
Publicado 2009

Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using Toll-like receptor 7 agonist imiquimod as vaccine adjuvant

por Adams, Sylvia, O'Neill, David W., Nonaka, Daisuke, Hardin, Elizabeth, Chiriboga, Luis, Siu, Kimberly, Cruz, Crystal M., Angiulli, Angelica, Angiulli, Francesca, Ritter, Erika, Holman, Rose Marie, Shapiro, Richard L., Berman, Russell S., Berner, Natalie, Shao, Yongzhao, Manches, Olivier, Pan, Linda, Venhaus, Ralph R., Hoffman, Eric W., Jungbluth, Achim, Gnjatic, Sacha, Old, Lloyd, Pavlick, Anna C., Bhardwaj, Nina
Publicado 2008

A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors

por Scott, Andrew M., Lee, Fook-Thean, Tebbutt, Niall, Herbertson, Rebecca, Gill, Sanjeev S., Liu, Zhanqi, Skrinos, Effie, Murone, Carmel, Saunder, Timothy H., Chappell, Bridget, Papenfuss, Anthony T., Poon, Aurora M. T., Hopkins, Wendie, Smyth, Fiona E., MacGregor, Duncan, Cher, Lawrence M., Jungbluth, Achim A., Ritter, Gerd, Brechbiel, Martin W., Murphy, Roger, Burgess, Antony W., Hoffman, Eric W., Johns, Terrance G., Old, Lloyd J.
Publicado 2007

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

por Davis, Ian D., Chen, Weisan, Jackson, Heather, Parente, Phillip, Shackleton, Mark, Hopkins, Wendie, Chen, Qiyuan, Dimopoulos, Nektaria, Luke, Tina, Murphy, Roger, Scott, Andrew M., Maraskovsky, Eugene, McArthur, Grant, MacGregor, Duncan, Sturrock, Sue, Tai, Tsin Yee, Green, Simon, Cuthbertson, Andrew, Maher, Darryl, Miloradovic, Lena, Mitchell, Susan V., Ritter, Gerd, Jungbluth, Achim A., Chen, Yao-Tseng, Gnjatic, Sacha, Hoffman, Eric W., Old, Lloyd J., Cebon, Jonathan S.
Publicado 2004